Trials / Completed
CompletedNCT06770647
Predicting Outcomes of Breast-Conserving Surgery in Breast Cancer Patients Using the Modified 5-Item Frailty Index
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 96,586 (actual)
- Sponsor
- Technical University of Munich · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Background: Breast cancer is the most common malignancy among women worldwide, with breast-conserving surgery (BCS) being a key treatment. The modified 5-item frailty index (mFI-5), a well-validated tool for assessing frailty, has shown predictive utility in other surgical contexts but remains under-explored in BCS. Methods: Using the American College of Surgeons National Surgical Quality Improvement Program database (2008-2021), the investigators identified adult female breast cancer patients who underwent BCS. Frailty was assessed using the mFI-5, scored from 0 to 5, with higher scores indicating greater frailty. Multivariable logistic regression was employed to evaluate associations between mFI-5 scores and postoperative outcomes. Main question: Can the mFI-5 predict adverse postoperative outcomes in breast-conserving surgery patients?
Conditions
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2024-08-01
- Completion
- 2024-12-15
- First posted
- 2025-01-13
- Last updated
- 2025-01-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06770647. Inclusion in this directory is not an endorsement.